The Board of Directors of SKAN Group AG has proposed Dr. Christian Schlogel as a new member for election at the company's Annual General Meeting on May 7, 2026. This nomination follows Patrick Schar's decision not to stand for re-election after 16 years of service on the board. The move signals a strategic emphasis on digital transformation and software integration for the pharmaceutical equipment manufacturer.
Dr. Christian Schlogel brings three decades of leadership experience in global technology, software, and industrial companies, with specific expertise in digital transformation and artificial intelligence. From 2018 to 2025, he served as Group Chief Digital Officer and member of the Executive Board of Korber AG, where he led digital transformation initiatives for approximately 14,000 employees. Previously, from 2014 to 2018, he was Group Chief Technology & Digital Officer at KUKA AG, an international automation and robotics group with around 15,000 employees.
Beat Lüthi, Chairman of the Board of Directors of SKAN Group, explained the strategic rationale behind the nomination: "SKAN expands its offering to include software and digital integration services, for which we acquired a majority stake in Metronik last year. In parallel, we are driving forward the digital transformation of the company and our services. Christian Schlögel can significantly support these initiatives, which are core elements of the strategy for future sales and margin growth, with his expertise."
The nomination reflects SKAN's broader strategic shift toward digital services and software integration in the pharmaceutical manufacturing sector. As a market leader in aseptic and aseptic-toxic manufacturing processes for the pharmaceutical industry, SKAN's expansion into digital services represents a significant evolution of its business model. The company's acquisition of Metronik last year established its entry into software and digital integration services, positioning it to offer more comprehensive solutions to pharmaceutical and biotech clients worldwide.
Patrick Schar's departure from the board after 16 years marks the end of an era for the company. Beat Lüthi acknowledged his contributions: "Patrick Schär has been on the Board of Directors for 16 years. With his professional background and experience as a financial expert, he has made a significant contribution to the development of the SKAN Group."
This board transition occurs as SKAN prepares to release its 2025 annual results on March 24, 2026, followed by the Annual General Meeting on May 7, 2026. The nomination of a digital transformation expert to the board suggests SKAN is positioning itself to compete more effectively in an increasingly digital pharmaceutical manufacturing landscape, where software integration and data analytics are becoming critical components of production efficiency and regulatory compliance. View the original release on www.newmediawire.com.
